Obstetric cholestasis with elevated gamma glutamyl transpeptidase: Incidence, presentation and treatment

作者: PIOTR MILKIEWICZ , RUTH GALLAGHER , JENNY CHAMBERS , ENID EGGINGTON , JUDITH WEAVER

DOI: 10.1046/J.1440-1746.2003.03171.X

关键词:

摘要: Background:  Obstetric cholestasis (OC) may cause severe pruritus in the mother and lead to fetal distress stillbirth. The etiology of OC is multifactorial, but includes inherited dysfunction bile canalicular transporters. One these, multidrug resistant protein 3 (MDR3), a phospholipid transporter, when dysfunctional associated with elevated levels gamma glutamyl transpeptidase (GGT). aim present study was assess incidence GGT. We compared natural history cholestatic pregnancy efficacy ursodeoxycholic acid (URSO) patients grouped according normal or raised GGT level. Methods:  Eighty-one were analyzed. diagnosed serum acids (SBA). Fifty-seven consenting volunteer (70%) treated URSO. Results:  Elevated at presentation found 21 (30%) significantly higher aspartate transaminase (AST), bilirubin (BIL) SBA. presented approximately same gestation week both groups patients. In not URSO, liver function tests (LFT) showed no significant change from time diagnosis delivery. Patients responded URSO improvement their AST alanine aminotransferase (ALT) levels, SBA fell only group. Conclusions:  An occurs less than one-third UK and, present, greater impairment LFT, difference gestational age onset. Treatment appears be safe improves LFT OC, exception high group.

参考文章(12)
Piotr Milkiewicz, Elwyn Elias, Catherine Williamson, Judith Weaver, Obstetric cholestasis: May have serious consequences for the fetus, and needs to be taken seriously BMJ. ,vol. 324, pp. 123- 124 ,(2002) , 10.1136/BMJ.324.7330.123
Ling-Jie Meng, Humberto Reyes, Jonquin Palma, Ismael Hernandez, José Ribalta, Jan Sjövall, Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy Journal of Hepatology. ,vol. 27, pp. 1029- 1040 ,(1997) , 10.1016/S0168-8278(97)80147-X
PLM Jansen, M Müller, The molecular genetics of familial intrahepatic cholestasis Gut. ,vol. 47, pp. 1- 5 ,(2000) , 10.1136/GUT.47.1.1
Joaquín Palma, Humberto Reyes, José Ribalta, Ismael Hernández, Lorena Sandoval, Ramón Almuna, Juris Liepins, Fernando Lira, Manuel Sedano, Octavio Silva, Dolores Tohá, Juan Jorge Silva, Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. Journal of Hepatology. ,vol. 27, pp. 1022- 1028 ,(1997) , 10.1016/S0168-8278(97)80146-8
E ELIAS, URSO in obstetric cholestasis: not a bear market Gut. ,vol. 45, pp. 331- 332 ,(1999) , 10.1136/GUT.45.3.331
Emmanuel Jacquemin, Danièle Cresteil, Sylvie Manouvrier, Odile Boute, Michelle Hadchouel, Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy The Lancet. ,vol. 353, pp. 210- 211 ,(1999) , 10.1016/S0140-6736(05)77221-4
Frank Lammert, Hanns-Ulrich Marschall, Anna Glantz, Siegfried Matern, Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management Journal of Hepatology. ,vol. 33, pp. 1012- 1021 ,(2000) , 10.1016/S0168-8278(00)80139-7
PH Dixon, N Weerasekera, KJ Linton, O Donaldson, J Chambers, E Egginton, J Weaver, C Nelson-Piercy, M de Swiet, G Warnes, E Elias, CF Higgins, DG Johnston, MI McCarthy, C Williamson, Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking Human Molecular Genetics. ,vol. 9, pp. 1209- 1217 ,(2000) , 10.1093/HMG/9.8.1209
Myriam Delhaye, Hubert Louis, Chantal Degraef, Olivier Le Moine, Jacques Devière, Marie-Odile Peny, Michael Adler, Paul Galand, None, Hepatocyte proliferative activity in human liver cirrhosis Journal of Hepatology. ,vol. 30, pp. 461- 471 ,(1999) , 10.1016/S0168-8278(99)80106-8